1. COMBINED VITRECTOMY AND INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT.
- Author
-
Zheng A, Chin EK, Almeida DR, Tsang SH, and Mahajan VB
- Subjects
- Adult, Aged, Aged, 80 and over, Combined Modality Therapy, Drug Implants, Female, Humans, Intraocular Pressure physiology, Intravitreal Injections, Macular Edema drug therapy, Macular Edema physiopathology, Macular Edema surgery, Male, Middle Aged, Retinal Vein Occlusion drug therapy, Retinal Vein Occlusion physiopathology, Retinal Vein Occlusion surgery, Retinal Vein Occlusion therapy, Retrospective Studies, Tomography, Optical Coherence, Uveitis, Posterior drug therapy, Uveitis, Posterior physiopathology, Uveitis, Posterior surgery, Uveitis, Posterior therapy, Visual Acuity physiology, Wet Macular Degeneration drug therapy, Wet Macular Degeneration physiopathology, Wet Macular Degeneration surgery, Wet Macular Degeneration therapy, Dexamethasone administration & dosage, Glucocorticoids administration & dosage, Macular Edema therapy, Vitrectomy methods
- Abstract
Purpose: To evaluate the safety and efficacy of combining intravitreal dexamethasone implantation (Ozurdex) with pars plana vitrectomy (PPV)., Methods: A retrospective review was conducted on cases where Ozurdex injection was performed in the operating room in conjunction with pars plana vitrectomy. Our primary outcome measure was the presence of surgical complications in the perioperative and 3-month postoperative window. We also measured visual acuity, intraocular pressure (IOP), and macular edema at baseline, one, and 3 months after surgery., Results: Fifteen eyes in 14 cases were reviewed. There were no complications intraoperatively or at 1-month postoperatively. Two patients (2 eyes) with prior retinal detachment developed proliferative vitreoretinopathy and redetachment at 3 months. Visual acuity improved in 7 of 15 eyes, and an average improvement of 2 lines was achieved for the entire cohort. There was no overall change in intraocular pressure although 1 patient developed an increase in intraocular pressure >5 mmHg. Five of 9 patients with baseline macular edema experienced improvement or resolution at 3 months., Conclusion: Intraoperative Ozurdex in combination with PPV may be safe and effective in treating macular edema caused by many different underlying diseases., Competing Interests: Disclosures: None.
- Published
- 2016
- Full Text
- View/download PDF